• Latest Posts
In Depth 23 Nov 2023

The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy

In Depth 22 Nov 2023

Apellis’ Syfovre vs Astellas’ Izervay: the battle for a geographic atrophy treatment

In Depth 16 Nov 2023

Meet the ‘biotech mafia’: how specialized biotech VC firms are dominating industry funding once again

In Depth 15 Nov 2023

Beyond oil and gas: Biotech’s significant place in the Qatar Investment Authority’s strategy

In Depth 9 Nov 2023

Blood tests for Alzheimer’s: a hit or a miss?

ADVERTISEMENT
In Depth 6 Nov 2023

The biggest private biotech investments in October 2023

In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

In Depth 30 Oct 2023

The ongoing search for an HIV cure: can CRISPR crack the code?

In Depth 27 Oct 2023

Big pharma monopolies: major antitrust cases over the past decade

In Depth 26 Oct 2023

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

In Depth 20 Oct 2023

Is Africa ready to become the next big biopharma and vaccine manufacturing destination?

ADVERTISEMENT